ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,335Medicare Part D Prescriptions Filled, Including Refills

Rank: 40 out of 288

$747K Total Retail Price of All Prescriptions

Rank: 18 out of 288

607 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 607 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

18% of this provider’s 607 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 10,466 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
LEVOTHYROXINE SODIUM 515 430 1 2
SIMVASTATIN 504 432 2 1
HYDROCODONE-ACETAMINOPHEN 434 348 S3 3 7
FUROSEMIDE 394 352 4 5
OMEPRAZOLE 356 321 5 3
WARFARIN SODIUM 311 295 6 9
AMLODIPINE BESYLATE 300 257 7 6
POTASSIUM CHLORIDE 267 258 8 11
LOSARTAN POTASSIUM 257 205 9 16
CITALOPRAM HBR 232 208 10 18
LISINOPRIL 224 194 11 4
METOPROLOL TARTRATE 216 209 12 8
GABAPENTIN 187 149 13 17
GLIMEPIRIDE 187 186 13 32
METFORMIN HCL 153 114 15 12
ATORVASTATIN CALCIUM 148 142 16 14
ZOLPIDEM TARTRATE 147 99 17 22
TRAMADOL HCL 140 113 18 19
METOPROLOL SUCCINATE 137 119 19 15
TAMSULOSIN HCL 130 118 20 24
NAMENDA 125 125 21 39
ALLOPURINOL 120 120 22 23
PREDNISONE 119 92 23 30
ALENDRONATE SODIUM 115 99 24 20
CELEBREX 114 91 25 84
ATENOLOL 113 91 26 10
FENTANYL 112 102 S2 27 57
ADVAIR DISKUS 107 103 28 50
LEVOFLOXACIN 105 96 29 80
MIRTAZAPINE 104 104 30 60
SPIRIVA 97 85 31 48
SPIRONOLACTONE 97 82 31 36
LYRICA 95 68 33 114
LANTUS 94 91 34 31
FLUTICASONE PROPIONATE 89 64 35 41
CYMBALTA 86 42 36 67
NABUMETONE 85 52 37 108
TRAZODONE HCL 80 59 38 37
MELOXICAM 78 54 39 44
POLYETHYLENE GLYCOL 3350 75 74 40 38
FENOFIBRATE 73 56 41 61
JANUVIA 73 68 41 88
BUMETANIDE 71 58 43 105
NEXIUM 70 52 44 43
SYNTHROID 67 65 45 63
ISOSORBIDE MONONITRATE ER 65 65 46 35
DIGOXIN 65 65 46 51
SERTRALINE HCL 64 52 48 25
PROAIR HFA 63 44 49 45
VYTORIN 63 51 49 150
QUETIAPINE FUMARATE 59 51 51 92
EXELON 59 59 51 185
CARVEDILOL 57 57 53 27
PANTOPRAZOLE SODIUM 55 44 54 42
CEPHALEXIN 53 46 55 83
DONEPEZIL HCL 53 53 55 29
DIOVAN 52 52 57 53
BENAZEPRIL HCL 50 50 58 52
PROPRANOLOL HCL 50 27 58 90
LEVETIRACETAM 50 38 58 125
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 19, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.